Codman & Shurtleff: Clinical Trials

2 trials sponsored by Codman & Shurtleff, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 31Terminated 1

Follow Codman & Shurtleff: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
VISSIT Intracranial Stent Study for Ischemic Therapy
Pharos Vitesse Neurovascular Stent System (Stent implantation) + Medical therapy (Aspirin and Clopidogrel), Aspirin and Clopidogrel (Medical therapy) - Ischemic Stroke, Transient Ischemic Attack
Phase 2 / Phase 3TerminatedCodman & Shurtleff1252008-10-012015-02-20
Study to Evaluate Efficacy of Shunt Operation for Idiopathic Normal Pressure Hydrocephalus
ventriculo-peritoneal shunt - Idiopathic Normal Pressure Hydrocephalus
Phase 2CompletedTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan1102004-09-012009-02-09

Conditions studied

Ischemic Attack, Transient (1)  ·  Ischemic Stroke (1)

Interventions

Aspirin (1)  ·  Clopidogrel (1)  ·  Ventriculoperitoneal Shunt (1)

Countries

Japan (1)

Top investigators

Masatsune Ishikawa, M.D. (1)

Results publications

PMID 21040519, PMID 21611722, PMID 22239832, PMID 25803346, PMID 28251346, PMID 34795635